126 related articles for article (PubMed ID: 37391891)
1. YKL-40 immunoexpression as a prognosticator of mycosis fungoides.
Neinaa YME; Elsayed HTI; Alshenawy HA; Gamei MM
Int J Dermatol; 2023 Sep; 62(9):1147-1153. PubMed ID: 37391891
[TBL] [Abstract][Full Text] [Related]
2. Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study.
Neinaa YME; El-Maadawy IH; Atteia IA; Mohamed DAE
Arch Dermatol Res; 2023 Oct; 315(8):2403-2411. PubMed ID: 36943432
[TBL] [Abstract][Full Text] [Related]
3. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
[TBL] [Abstract][Full Text] [Related]
4. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
6. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
8. Detection of telomerase activity in patients with mycosis fungoides.
Zuolin Y; Jianfang S; Shan L
Chin Med Sci J; 2003 Jun; 18(2):124-7. PubMed ID: 12903797
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric identification of immunophenotypically aberrant T-cell clusters on skin shave biopsy specimens from patients with mycosis fungoides.
Horna P; Kurant D; Sokol L; Sotomayor EM; Moscinski L; Glass LF
Am J Clin Pathol; 2015 Jun; 143(6):785-96. PubMed ID: 25972320
[TBL] [Abstract][Full Text] [Related]
10. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
Lebowitz E; Geller S; Flores E; Pulitzer M; Horwitz S; Moskowitz A; Kheterpal M; Myskowski PL
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):108-114. PubMed ID: 30176169
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center.
Geller S; Lebowitz E; Pulitzer MP; Horwitz SM; Moskowitz AJ; Dusza S; Myskowski PL
J Am Acad Dermatol; 2020 Aug; 83(2):430-439. PubMed ID: 31499157
[TBL] [Abstract][Full Text] [Related]
12. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
13. Dermoscopic spectrum of mycosis fungoides: a retrospective observational study by the International Dermoscopy Society.
Errichetti E; Apalla Z; Geller S; Sławińska M; Kyrgidis A; Kaminska-Winciorek G; Jurakic Toncic R; Bobos M; Rados J; Ledic Drvar D; Ceovic R; Akay BN; Piccolo V; Myskowski P; Vitiello P; Russo T; Argenziano G; Sokołowska-Wojdyło M; Sobjanek M; Stojkovic-Filipovic J; Longo C; Pellacani G; Stinco G; Lallas A
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1045-1053. PubMed ID: 35285088
[TBL] [Abstract][Full Text] [Related]
14. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.
Wood GS; Bahler DW; Hoppe RT; Warnke RA; Sklar JL; Levy R
J Invest Dermatol; 1993 Sep; 101(3):296-300. PubMed ID: 8396607
[TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
Quaglino P; Zaccagna A; Verrone A; Dardano F; Bernengo MG
Dermatology; 1999; 199(1):8-14. PubMed ID: 10449950
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
17. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
[TBL] [Abstract][Full Text] [Related]
18. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
[TBL] [Abstract][Full Text] [Related]
19. PUVA-induced pityriasis lichenoides chronica-like papular lesions in patients with mycosis fungoides: a clinical, histopathological and immunohistochemical study.
Youssef R; Abdel-Halim MRE; Abdel Halim DM; Fawzy MM; Hussein MF; Elmasry MF; Sayed SS; Abo Eid NM
Arch Dermatol Res; 2019 Nov; 311(9):673-678. PubMed ID: 31300833
[TBL] [Abstract][Full Text] [Related]
20. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
